AAOS Now, August 2008
The seductiveness of supplements
Orthopaedic surgeons are seeing increased use of PEDs Sylvester Stallone says human growth hormone (HGH) “increases the quality of your life.” Arnold Schwarzenegger says he has “no regrets” about using steroids. With endorsements like that, it’s no wonder that Americans—particularly Americans of a certain age—are turning to performance-enhancing drugs (PEDs). As part of our continuing series examining PED use, AAOS Now contributing editor Michael F.
ASRA recommendations on systemic toxicity of local anesthetics
The American Society of Regional Anesthesia (ASRA) has developed a series of recommendations addressing the systemic toxicity of local anesthetics. The AAOS Council on Research, Quality Assessment and Technology reviewed the recommendations, and the AAOS Board of Directors, at its meeting on June 12, 2008, agreed to publish them in AAOS Now. Prevention of systemic local anesthetic toxicity Be vigilant.
Finding better knee implant materials
Study examines outcomes with highly cross-linked polyethylene “Highly cross-linked polyethylene has been proven to have significant resistance to wear in total hip arthroplasty (see “Creep and wear in THA” below); in total knee arthroplasty (TKA), it’s controversial,” says Erik P. Severson, MD, of the University of Utah. “In TKA, highly cross-linked polyethylene is generally believed to have less resistance to crack propagation than standard polyethylene.” And yet, says Dr.
Alexander Afalonis, MD June 6, 2008 Jamaica, N.Y. Paul M. Beegel, MD March 21, 2008 Auburn, Maine Burton L. Berson, MD July 13, 2008 Atlantic Beach, N.Y. Charles W. Brown, MD June 15, 2005 Englewood, Colo. John Goodwyne Caden Jr., MD Nov. 23, 2007 Jackson, Miss. George R. Callender Jr., MD Unknown Easton, Md. Elliot L. Coles, MD June 19, 2008 Milwaukee, Wis. Glenn H. Connelly, MD May 18, 2003 Foster City, Calif. Clyde X. Copeland Jr.
Staying out of trouble with tumors
Musculoskeletal oncologists offer important guidance for nontumor surgeons “Patients who have bone and soft-tissue lesions present challenges to the practicing orthopaedic surgeon,” said Theodore W. Parsons III, MD. “Treating these patients can be anxiety-provoking for the surgeon—as well as the patient—with the looming question being whether the lesion is malignant or benign.” Dr. Parsons, along with musculoskeletal oncologists Kristy L. Weber, MD, Denis R. Clohisy, MD, and Frank J.
Attacking MRSA in children
Noted pharmacologist outlines treatment options Methicillin-resistant Staphylococcus aureus (MRSA) is a rapidly emerging concern for physicians and hospitals. How to deal with it and what new treatment options may soon become available were covered by B. Joseph Guglielmo, PharmD, at the Pediatric Orthopaedic Society of North America 2008 specialty day meeting. “I have three messages,” said Dr. Guglielmo. “First, the rate of MRSA is increasing.
Second Look – Clinical News and Views
If you missed these Headline News Now items the first time around, AAOS Now gives you a second chance to review them. Headline News Now—the AAOS thrice-weekly, e-mail update of news of interest to orthopaedic surgeons—brings you the latest on clinical, socioeconomic, and political issues, as well as important announcements from AAOS.
Meetings and Course Listings
Listed below are upcoming continuing medical education (CME) courses and orthopaedic meetings (September through December). For more information about AAOS-sponsored courses, contact the AAOS customer service department at (800) 626-6726. For more information about other CME courses or orthopaedic meetings listed, contact the source provided.